Moneycontrol PRO
HomeNewsAjantapharma
Jump to
  • Buy Ajanta Pharma; target of Rs 2400: Ajcon Global

    Ajcon Global is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated March 08, 2022.

  • Buy Ajanta Pharmaceuticals; target of Rs 2605: ICICI Direct

    Buy Ajanta Pharmaceuticals; target of Rs 2605: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2605 in its research report dated February 02, 2021.

  • Buy Ajanta Pharma; target of Rs 2780: Motilal Oswal

    Buy Ajanta Pharma; target of Rs 2780: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2780 in its research report dated July 30, 2021.

  • Buy Ajanta Pharmaceuticals; target of Rs 2250: ICICI Direct

    Buy Ajanta Pharmaceuticals; target of Rs 2250: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2250 in its research report dated May 01, 2021.

  • Buy Ajanta Pharma; target of Rs 2205: Dolat Capital Market

    Buy Ajanta Pharma; target of Rs 2205: Dolat Capital Market

    Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2205 in its research report dated April 30, 2021.

  • Buy Ajanta Pharma; target of Rs 2030: Motilal Oswal

    Buy Ajanta Pharma; target of Rs 2030: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2030 in its research report dated February 02, 2021.

  • Buy Ajanta Pharma; target of Rs 2208: Dolat Capital Market

    Buy Ajanta Pharma; target of Rs 2208: Dolat Capital Market

    Dolat Capital Market is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2208 in its research report dated February 03, 2021.

  • Buy Ajanta Pharma; target of Rs 1980: Anand Rathi

    Buy Ajanta Pharma; target of Rs 1980: Anand Rathi

    Anand Rathi is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1980 in its research report dated November 05, 2020.

  • Accumulate Ajanta Pharma; target of Rs 1771: Dolat Capital Market

    Accumulate Ajanta Pharma; target of Rs 1771: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Ajanta Pharma with a target price of Rs 1771 in its research report dated November 05, 2020.

  • Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct

    Buy Ajanta Pharmaceuticals; target of Rs 1960: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated November 04, 2020.

  • Accumulate Ajanta Pharma; target of Rs 1676: Dolat Capital

    Accumulate Ajanta Pharma; target of Rs 1676: Dolat Capital

    Dolat Capital recommended accumulate rating on Ajanta Pharma with a target price of Rs 1676 in its research report dated August 01, 2020.

  • Buy Ajanta Pharmaceuticals; target of Rs 1810: ICICI Direct

    Buy Ajanta Pharmaceuticals; target of Rs 1810: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1810 in its research report dated July 31, 2020.

  • Buy Ajanta Pharmaceuticals; target of Rs 1730: ICICI Direct

    Buy Ajanta Pharmaceuticals; target of Rs 1730: ICICI Direct

    ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated May 22, 2020.

  • Buy Ajanta Pharma; target of Rs 1700: Motilal Oswal

    Buy Ajanta Pharma; target of Rs 1700: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated May 20, 2020.

  • Hold Ajanta Pharmaceuticals; target of Rs 1010: ICICI Direct

    Hold Ajanta Pharmaceuticals; target of Rs 1010: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1010 in its research report dated August August 01, 2019.

  • Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct

    Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1060 in its research report dated May 02, 2019.

  • Buy Ajanta Pharma; target of Rs 1080: Keynotes Financial Opiniery

    Buy Ajanta Pharma; target of Rs 1080: Keynotes Financial Opiniery

    Keynotes Financial Opiniery is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated March 15, 2019.

  • Hold Ajanta Pharmaceuticals; target of Rs 1100: ICICI Direct

    Hold Ajanta Pharmaceuticals; target of Rs 1100: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1100 in its research report dated February 01, 2019.

  • Buy Ajanta Pharma; target of Rs 1390: Motilal Oswal

    Buy Ajanta Pharma; target of Rs 1390: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1390 in its research report dated January 30, 2019.

  • Hold Ajanta Pharmaceuticals; target of Rs 1190: ICICI Direct

    Hold Ajanta Pharmaceuticals; target of Rs 1190: ICICI Direct

    ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1190 in its research report dated May 03, 2018.

  • Hold Ajanta Pharma; target of Rs 1520: Spa Research

    Hold Ajanta Pharma; target of Rs 1520: Spa Research

    Spa Research is bullish on Ajanta Pharma has recommended hold rating on the stock with a target price of Rs 1520 in its research report dated February 01, 2018.

  • Mangalam Drugs & Organics – valuation comfort for this small cap

    Mangalam Drugs & Organics – valuation comfort for this small cap

    For a company on a turnaround journey where the return ratios have started looking up meaningfully, the undemanding valuation at 9X FY19 projected earnings should be looked at seriously by investors

  • Buy Ajanta Pharma; target of Rs 1520: SPA Securities

    Buy Ajanta Pharma; target of Rs 1520: SPA Securities

    SPA Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated November 09, 2017.

  • Buy Ajanta Pharma; target of Rs 1500: Reliance Securities

    Buy Ajanta Pharma; target of Rs 1500: Reliance Securities

    Reliance Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1500 in its research report dated November 01, 2017.

  • Buy Ajanta Pharma; target of Rs 1605: Motilal Oswal

    Buy Ajanta Pharma; target of Rs 1605: Motilal Oswal

    Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1605 in its research report dated October 12, 2017.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347